India Pharmaceuticals & Healthcare Report Q2 2014: New Research Report Available at Fast Market Research
Pharmaceutical firms in India are reporting improved performance for the quarter ended December 2013. This is an early indication of a recovery in the Indian pharmaceutical industry, following the implementation of the Drug Price Control Order in May 2013. While we forecast strong growth for the sector in 2014, persisting issues such as the halting of clinical trials, low healthcare expenditure and company-specific manufacturing quality control problems will continue to pose downside risks to our outlook.
View full press release